Pengfei Xu

10PUBLICATIONS
25CO-AUTHORS
Medical devicesEpidemiological modellingAutonomic nervous systemMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 19, 2026
Targeting ADAR1-mediated RNA editing inhibits hepatic stellate cell activation and liver fibrosis by enhancing HSC-intrinsic innate immunity.

Yue Xi, Lingyi Liu, Jong-Won Kim

|Sep 29, 2025
A loss-of-function human ADAR variant activates innate immune response and promotes bowel inflammation.

Pengfei Xu, Yue Xi, Jong-Won Kim

|Sep 25, 2024
Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose.

Hung-Chun Tung, Jong-Won Kim, Junjie Zhu

|Jun 10, 2023
Nuclear Receptors in Health and Diseases.

Pengfei Xu

|Feb 11, 2023
Constitutive Androstane Receptor Agonist, TCPOBOP: Maternal Exposure Impairs the Growth and Development of Female Offspring in Mice.

Shijia Pan, Yuan Guo, Wen Yu

|Dec 09, 2022
Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040.

Chun-Quan Liu, Yun-Lei Ma, Qi Qin

Pageof 2

Frequent Collaborators

4 joint publications

Wen Xie

4 joint publications

Da Yang

3 joint publications

Yue Xi

2 joint publications

Xiaojie Quan